GLP-1 medication users, compounding pharmacy patients (Hallandale, Strive, Empower), and anyone working with longer-profile 3mL vials
TGR5 and bile acid TGR5 is a member of the G-protein-coupled receptor superfamily and is expressed in various tissues, including pancreas Cells, endocrine cells in the small intestine, thyroid, brown adipose tissue, cardiomyocytes, and macrophages [11, 13]
Food and Drug Administration (FDA) include semaglutide (sold as Ozempic and Wegovy), liraglutide (Saxenda and Victoza), and tirzepatide (Zepbound), a dual GIP/GLP-1 receptor agonist
J Biol Chem (1997) 272(52):328106
Step therapy placement is quantifiably addressable through clinical superiority data submitted to PBM clinical criteria committees